CLINICAL PREDICTORS OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A RETROSPECTIVE COHORT ANALYSIS
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Objective: Identify clinical and biochemical predictors of major adverse cardiovascular events in rheumatoid arthritis (2010–2024), quantifying the contributions of traditional risk factors (dyslipidemia, hypertension, diabetes) and RA-related (Rheumatoid Arthritis) disease characteristics. Methods: We conducted a retrospective cohort study of 232 adults with rheumatoid arthritis (RA) followed at our rheumatology clinic between January 2010 and March 2024. RA was classified by the 2010 ACR/EULAR criteria. Demographics (age, sex), disease duration, body mass index, smoking, and comorbidities (hypertension, diabetes, dyslipidemia, chronic kidney disease) were extracted from records. Baseline laboratories included erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), urea, creatinine, lipid profile (total, low-density lipoprotein (LDL), high-density lipoprotein (HDL) cholesterol, triglycerides), uric acid, and HbA1c. Disease markers (RF, anti-CCP, HLA-B27), cumulative treatment exposure, treatment modifications, and use of csDMARDs (Disease-modifying antirheumatic drug), bDMARDs (Tumor Necrosis Factor (TNF/non-TNF)), and Januse Kinase (JAK) inhibitors were recorded. Patients were stratified by major adverse cardiovascular events (Major adverse cardiovascular events (MACE): non-fatal MI (Miyocardial Infarction), ischemic stroke, cardiovascular death, or coronary revascularization). Results: Results: MACE occurred in 41 patients. Compared with those without MACE, affected patients were older and had more treatment changes and prior biologic exposures. They showed worse renal indices (higher urea/creatinine) and an adverse metabolic profile— higher total cholesterol, LDL-cholesterol, triglycerides, and HbA1c. Sex, disease duration, Body Mass Index (BMI), ESR/CRP, time to first bDMARD, Aspartate Transaminase (AST), Alanine Transaminase (ALT), uric acid and HDL did not differ. Cardiometabolic comorbidities were strongly enriched among MACE cases (hypertension, diabetes, dyslipidemia). In multivariable logistic regression, dyslipidemia remained the only independent predictor of MACE (OR 27.04; 95% CI 9.18–79.68; p
Fields of Study & Subjects
Rheumatoid Arthritis Research and Therapies
Gout
Hyperuricemia
Uric Acid
Cardiovascular Health and Risk Factors
Publication details
- Journal / source
- Rheumatology Quarterly
- Volume
- 4
- Issue
- 1
- Pages
- 47–52
- Publication date
- 30 March 2026
- Language
- EN